ExpressionEdits' Genetic Syntax Engine platform is designed to enhance gene expression within gene therapies by restoring introns.

Boehringer Ingelheim said its experimental treatment for a chronic lung disease succeeded in a pivotal study, and it's taking ...

Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...

In a swift reversal, President Donald Trump on Monday undid the Biden administration's last-minute bid to remove Cuba from the U.S. list of state sponsors of terrorism, the White House announced. This ...

Building on this legacy of innovation, LG did the unthinkable yet again with the announcement of the first-ever transparent OLED TV in the world in 2024. LG's see-through 77" TV with 4K UHD ...

BI-765845 is under clinical development by Boehringer Ingelheim International and currently in Phase II for Myocardial Infarction. According to GlobalData, Phase II drugs for Myocardial Infarction ...

With immense popularity comes an equal measure of responsibility, says actor Wi Ha-joon, the 'Squid Game' star driven by the show's global acclaim to deliver his finest performances. The 33-year-old ...

On Windows 11, desktop elements like the Taskbar, Start menu, and certain apps, such as the Settings app, use a new transparent base layer featuring the Mica material from the Microsoft Fluent ...

TRANSITIONING between Transparent to Opaque Screen, LG SIGNATURE OLED T Introduces New Viewing Possibilities and a New Era in Home Entertainment LG Electronics (LG) is set for the global launch of the ...

Boehringer Ingelheim’s trio of late-stage schizophrenia failures on Thursday came a day after the Department of Health and Human Services hit back on the pharma’s legal challenge to the IRA’s drug ...

HHS told the Sec­ond Cir­cuit that Boehringer In­gel­heim’s vol­un­tary par­tic­i­pa­tion in Medicare ne­go­ti­a­tions “un­der­mines” its le­gal chal­lenge to the process.

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...